Diabetes Mellitus Clinical Trial
Official title:
The Impact of Pharmacist Recommendations on Quality of Care in Diabetic Patients
The goal of this study is to investigate a comprehensive provider-focused intervention to improve the quality of care for diabetic patients in a large primary care practice at Brigham and Women's Hospital. This will be accomplished through pharmacist recommendations provided to primary care providers prior to routine scheduled office visits for diabetic patients.
Type II diabetes mellitus is an increasingly common condition among adults in the United
States and is associated with substantial morbidity and mortality. The microvascular and
macrovascular complications of diabetes lead to significant disability and early mortality,
in addition to tremendous costs to the healthcare system. It has been clearly demonstrated,
that both microvascular and macrovascular complications can be reduced through specific
interventions that can be carried out by office-based primary care physicians. Despite the
accumulation of evidence regarding specific interventions that can reduce diabetes-related
morbidity and mortality, multiple studies have shown that the care provided for diabetic
patients frequently falls short of recommended standards.
The researcher's goal is to investigate a comprehensive, provider-focused intervention to
improve the quality of care for diabetic patients in a large, primary care practice at
Brigham and Women's Hospital. This will be accomplished through pharmacist-delivered
recommendations provided to primary care providers prior to routine scheduled office visits
for diabetic patients.
Adult diabetic patients age 18 years and older receiving primary care in the Brigham
Internal Medicine Associates (BIMA) practice will be randomized to intervention and control
groups, based on the practice subset (Suite) within BIMA in which they receive their ongoing
care. Patients who receive care from providers in Suites A, B, E, and F will be assigned to
the intervention group, while patients who receive care from providers in Suites C, D, G,
and H will be assigned to the control group. Patients will not be contacted regarding the
study; providers who practice in the intervention Suites will receive specific written
recommendations regarding optimal diabetes care parameters from our study pharmacist prior
to each patient's visit. Providers who practice in the control Suites will not be contacted.
Pre- and post-intervention compliance with multiple diabetes quality-of-care measures (eg,
Hemoglobin A1c measurement, LDL cholesterol measurement, pneumococcal vaccination, etc.)
will be assessed in the intervention and control groups.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03743779 -
Mastering Diabetes Pilot Study
|
||
| Completed |
NCT03786978 -
Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus
|
N/A | |
| Completed |
NCT01804803 -
DIgital Assisted MONitoring for DiabeteS - I
|
N/A | |
| Completed |
NCT05039970 -
A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Completed |
NCT04068272 -
Safety of Bosentan in Type II Diabetic Patients
|
Phase 1 | |
| Completed |
NCT03243383 -
Readmission Prevention Pilot Trial in Diabetes Patients
|
N/A | |
| Completed |
NCT03730480 -
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
|
N/A | |
| Recruiting |
NCT02690467 -
Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.
|
N/A | |
| Completed |
NCT02229383 -
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
|
Phase 3 | |
| Completed |
NCT06181721 -
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
|
N/A | |
| Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
| Recruiting |
NCT04489043 -
Exercise, Prediabetes and Diabetes After Renal Transplantation.
|
N/A | |
| Withdrawn |
NCT03319784 -
Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients
|
Phase 4 | |
| Completed |
NCT03542084 -
Endocrinology Auto-Triggered e-Consults
|
N/A | |
| Completed |
NCT02229396 -
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
|
Phase 3 | |
| Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
| Completed |
NCT01892319 -
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
|
||
| Completed |
NCT05031000 -
Blood Glucose Monitoring Systems: Discounter Versus Brand
|
N/A | |
| Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A |